Skip to Main Content

Author Details

Carrie M Rosenberger
Genentech Inc.
2000
44
28
PMIDPaper TitleJournal TitlePublished Year
36929625Prognostic value of severe acute respiratory syndrome coronavirus-2 viral load and antibodies in patients hospitalized with COVID-19.Clin Transl Sci2023
37664617Transcriptomic and proteomic assessment of tocilizumab response in a randomized controlled trial of patients hospitalized with COVID-19.iScience2023
37312169Early plasma angiopoietin-2 is prognostic for ARDS and mortality among critically ill patients with sepsis.Crit Care2023
36519984Astegolimab or Efmarodocokin Alfa in Patients With Severe COVID-19 Pneumonia: A Randomized, Phase 2 Trial.Crit Care Med2023
34842360Surfactant protein D is a biomarker of influenza-related pediatric lung injury.Pediatr Pulmonol2022
34612846Prognostic and Predictive Biomarkers in Patients With Coronavirus Disease 2019 Treated With Tocilizumab in a Randomized Controlled Trial.Crit Care Med2022
34350278High serum granulocyte-colony stimulating factor characterises neutrophilic COPD exacerbations associated with dysbiosis.ERJ Open Res2021
33754705Serum Lysophosphatidic Acid Measurement by Liquid Chromatography-Mass Spectrometry in COPD Patients.J Am Soc Mass Spectrom2021
34556083Lysophosphatidic acid species are associated with exacerbation in chronic obstructive pulmonary disease.BMC Pulm Med2021
32082571Risk stratification biomarkers for <i>Staphylococcus aureus</i> bacteraemia.Clin Transl Immunology2020
31024970Sustained Circulating Bacterial Deoxyribonucleic Acid Is Associated With Complicated <i>Staphylococcus aureus</i> Bacteremia.Open Forum Infect Dis2019
30165412A Prognostic Model of Persistent Bacteremia and Mortality in Complicated Staphylococcus aureus Bloodstream Infection.Clin Infect Dis2019
31041341Prognostic Power of Pathogen Cell-Free DNA in Staphylococcus aureus Bacteremia.Open Forum Infect Dis2019
27872061Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients.Antimicrob Agents Chemother2017
28380049miR-144 attenuates the host response to influenza virus by targeting the TRAF6-IRF7 signaling axis.PLoS Pathog2017
29269431Reply to Hunsberger and Memoli, "Efficacy Analysis in Healthy-Volunteer Influenza Challenge Trials: Intention To Treat".Antimicrob Agents Chemother2017
28807912Phase 2 Randomized Trial of the Safety and Efficacy of MHAA4549A, a Broadly Neutralizing Monoclonal Antibody, in a Human Influenza A Virus Challenge Model.Antimicrob Agents Chemother2017
28531322Evaluation of IFITM3 rs12252 Association With Severe Pediatric Influenza Infection.J Infect Dis2017
28714988SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans.Nat Med2017
27354365Generation and Protective Ability of Influenza Virus-Specific Antibody-Dependent Cellular Cytotoxicity in Humans Elicited by Vaccination, Natural Infection, and Experimental Challenge.J Infect Dis2016
27653831Pharmacokinetics and pharmacodynamics of DSTA4637A: A novel THIOMABâ¿¢ antibody antibiotic conjugate against Staphylococcus aureus in mice.MAbs2016
24243730Characterization of innate responses to influenza virus infection in a novel lung type I epithelial cell model.J Gen Virol2014
25977790A comprehensive collection of systems biology data characterizing the host response to viral infection.Sci Data2014
24073225Differential host response, rather than early viral replication efficiency, correlates with pathogenicity caused by influenza viruses.PLoS One2013
23169590miR-451 regulates dendritic cell cytokine responses to influenza infection.J Immunol2012
21285433A systems biology approach to infectious disease research: innovating the pathogen-host research paradigm.mBio2011
17910742Toll-like receptor 2 plays a critical role in maintaining mucosal integrity during Citrobacter rodentium-induced colitis.Cell Microbiol2008
18227166Flagellin-dependent and -independent inflammatory responses following infection by enteropathogenic Escherichia coli and Citrobacter rodentium.Infect Immun2008
18321385The Innate Immune Database (IIDB).BMC Immunol2008
18268321ATF3 regulates MCMV infection in mice by modulating IFN-gamma expression in natural killer cells.Proc Natl Acad Sci U S A2008
18369420Uncovering a macrophage transcriptional program by integrating evidence from motif scanning and expression dynamics.PLoS Comput Biol2008
18397382Nramp1 expression by dendritic cells modulates inflammatory responses during Salmonella Typhimurium infection.Cell Microbiol2008
16622187Toll-like receptor 4 contributes to colitis development but not to host defense during Citrobacter rodentium infection in mice.Infect Immun2006
17114497IRAK-4 mutation (Q293X): rapid detection and characterization of defective post-transcriptional TLR/IL-1R responses in human myeloid and non-myeloid cells.J Immunol2006
14983025Interplay between antibacterial effectors: a macrophage antimicrobial peptide impairs intracellular Salmonella replication.Proc Natl Acad Sci U S A2004
15186400Differential post-transcriptional activation of human phagocytes by different Pseudomonas aeruginosa isolates.Cell Microbiol2004
12728272Phagocyte sabotage: disruption of macrophage signalling by bacterial pathogens.Nat Rev Mol Cell Biol2003
11821396Macrophages inhibit Salmonella typhimurium replication through MEK/ERK kinase and phagocyte NADPH oxidase activities.J Biol Chem2002
11553563Enteropathogenic Escherichia coli infection induces expression of the early growth response factor by activating mitogen-activated protein kinase cascades in epithelial cells.Infect Immun2001
11207622SifA permits survival and replication of Salmonella typhimurium in murine macrophages.Cell Microbiol2001
11755425Gene array technology to determine host responses to Salmonella.Microbes Infect2001
10820271Salmonella typhimurium infection and lipopolysaccharide stimulation induce similar changes in macrophage gene expression.J Immunol2000
11102822Microbial pathogenesis: lipid rafts as pathogen portals.Curr Biol2000
10975854An alpha-helical cationic antimicrobial peptide selectively modulates macrophage responses to lipopolysaccharide and directly alters macrophage gene expression.J Immunol2000
  • 1 - 44 of 44

Recommended Authors

J. David Gladstone Institutes
Career Start Year 2015
Number of shared co-authors 0
University College London
Career Start Year 2013
Number of shared co-authors 0
Massachusetts Institute of Technology, USA The Ragon Institute of MGH
Career Start Year 2012
Number of shared co-authors 1
Mater Dei Hospital, University of Malta
Career Start Year 2009
Number of shared co-authors 3
Benaroya Research Institute at Virginia Mason
Career Start Year 2007
Number of shared co-authors 6
Institute for Systems Biology
Career Start Year 2006
Number of shared co-authors 1
University of California san francisco
Career Start Year 2006
Number of shared co-authors 1
College of Osteopathic Medicine, Michigan State University
Career Start Year 2006
Number of shared co-authors 1
University of Virginia School of Medicine
Career Start Year 2003
Number of shared co-authors 0
United States Army Medical Research Institute of Infectious Diseases
Career Start Year 2003
Number of shared co-authors 0
Institute for Genomic Medicine, Columbia University
Career Start Year 2002
Number of shared co-authors 2
South Australian Health and Medical Research Institute
Career Start Year 2002
Number of shared co-authors 1
David Geffen School of Medicine, University of California Los Angeles
Career Start Year 2002
Number of shared co-authors 0
University of California berkeley
Career Start Year 2001
Number of shared co-authors 2
Texas A&M University School of Medicine
Career Start Year 2001
Number of shared co-authors 0
Frazer Institute, The University of Queensland
Career Start Year 2001
Number of shared co-authors 0
Trinity College Dublin
Career Start Year 2001
Number of shared co-authors 0
Duke University School of Medicine
Career Start Year 1998
Number of shared co-authors 3
Department of Microbial Pathogenesis Yale University New Haven
Career Start Year 1998
Number of shared co-authors 3
Indiana University School of Medicine
Career Start Year 1997
Number of shared co-authors 0
St. Paul's Hospital, University of British Columbia
Career Start Year 1994
Number of shared co-authors 1
David Geffen School of Medicine, University of California Los Angeles
Career Start Year 1994
Number of shared co-authors 0
University College London
Career Start Year 1992
Number of shared co-authors 0
university of california san diego School of Medicine
Career Start Year 1991
Number of shared co-authors 1
Center for Experimental and Molecular Medicine, University of Amsterdam
Career Start Year 1990
Number of shared co-authors 5
Yale University
Career Start Year 1990
Number of shared co-authors 1
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 2
The Ohio State University, Wexner Medical Center
Career Start Year 1988
Number of shared co-authors 1
University of Washington
Career Start Year 1986
Number of shared co-authors 8
UK System Immunity Research Institute, Cardiff University
Career Start Year 1985
Number of shared co-authors 1

Collaborators

Seattle Children's Research Institute
Co-authored papers 9
Universidad Antonio Narino
Co-authored papers 5
B.C. Children's Hospital
Co-authored papers 5
St. Jude Children's Research Hospital
Co-authored papers 5
Seattle Children's Research Institute
Co-authored papers 4
Center for Infectious Disease Research
Co-authored papers 4
Center for Infectious Disease Research
Co-authored papers 4
University of British Columbia
Co-authored papers 3
St. Jude Children's Research Hospital
Co-authored papers 3
St. Jude Children's Research Hospital
Co-authored papers 3
Seattle Biomedical Research Institute
Co-authored papers 3
Duke University School of Medicine
Co-authored papers 3
Boston Children's Hospital, Harvard Medical School
Co-authored papers 3
Duke University School of Medicine
Co-authored papers 3
Co-authored papers 2
Co-authored papers 2
Department of Pharmacy, Fuzhou Second Hospital
Co-authored papers 2
Genentech Inc.
Co-authored papers 2
Institute for Systems Biology
Co-authored papers 2
University of Washington
Co-authored papers 2
Institute for Systems Biology
Co-authored papers 2
Co-authored papers 2
University of California San Francisco
Co-authored papers 2
University of Washington
Co-authored papers 2
University of Washington, USA Washington National Primate Research Center
Co-authored papers 2
Institute for Systems Biology
Co-authored papers 2
Genentech Inc.
Co-authored papers 2
Pacific Northwest National Laboratory
Co-authored papers 2
Early Clinical Development, Inc.
Co-authored papers 2
Temple University
Co-authored papers 2